Market Overview

UPDATE: Auriga Raises Price Target on Allscripts-Misys to $25


According to Auriga, Allscripts-Misys (NASDAQ: MDRX) price target is raised to $25.

Auriga said that it is reiterating its BUY rating on Allscripts (MDRX) following an in-line quarter and guide. “Our new target, up from $23, is based on our newly introduced FY13 estimates.”

Allscripts-Misys closed yesterday at $21.47.

Posted-In: AurigaAnalyst Color Price Target Analyst Ratings


Related Articles (MDRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→